[1]
K. Geving Andersen, M.-B. Jensen, H. Kehlet, R. Gärtner, L. Eckhoff, and N. Kroman, “Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: Cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide”, AO, vol. 51, no. 8, pp. 1036–1044, Nov. 2012.